At what dose does 4-AcO-DMT produce runny nose?

Effects like runny nose are typically reported at common doses and above. A common insufflated dose of 4-AcO-DMT is 15–25 mg.

What other substances cause runny nose?

Other substances documented to produce runny nose include 4-HO-DET, 4-AcO-MET, Dichloropane, 4-AcO-MiPT, 25N-NBOMe, and 3 more.

Runny nose from 4-AcO-DMT — Detailed Guide

Q: Does 4-AcO-DMT cause runny nose?

Yes. Runny nose is a documented physical effect of 4-AcO-DMT. Excessive nasal discharge commonly occurring during opioid withdrawal or from nasal irritation caused by insufflated substances.

Runny nose from 4-AcO-DMT

physicalPsychedelic

Runny nose + 4-AcO-DMT

Effect category

physical

Substance class

Psychedelic

Chemical class

Substituted tryptamines

Routes of administration

insufflated, oral

Other effects from 4-AcO-DMT

103

Other substances causing this effect

Runny nose + 4-AcO-DMT

Effect category

physical

Substance class

Psychedelic

Chemical class

Substituted tryptamines

Routes of administration

insufflated, oral

Other 4-AcO-DMT effects

103

Substances causing runny nose

4-AcO-DMT is known to produce runny nose, a physical effect. Excessive nasal discharge commonly occurring during opioid withdrawal or from nasal irritation caused by insufflated substances.

About Runny nose

Runny nose (rhinorrhea) in the context of psychoactive substance use refers to excessive production and discharge of nasal mucus. The nasal mucosa is a highly vascularized tissue that produces mucus continuously as part of its role in humidifying and filtering inhaled air. Psychoactive substances can dramatically increase this baseline mucus production through several mechanisms.

During opioid withdrawal, rhinorrhea is one of the hallmark early symptoms, typically appearing within 8-24 hours after the last dose of a short-acting opioid. The mechanism involves sympathetic nervous system rebound. Chronic opioid use suppresses autonomic activity through mu-opioid receptor activation. When opioids are discontinued, the sudden removal of this suppression results in a surge of noradrenergic and cholinergic activity that stimulates mucus-secreting glands throughout the body, including the nasal mucosa. The rhinorrhea is typically accompanied by other withdrawal symptoms: lacrimation (watery eyes), yawning, sweating, piloerection (goosebumps), and muscle aches.

Direct nasal mucosal irritation is the primary cause of rhinorrhea associated with insufflated substances. Snorting any powdered substance irritates the delicate nasal epithelium, triggering an inflammatory response that increases mucus production as a protective mechanism. Substances that are caustic, have extreme pH values, or contain adulterants are particularly irritating. Cocaine is especially damaging to nasal tissue because it also causes intense local vasoconstriction, which reduces blood supply to the mucosa and can lead to tissue necrosis with chronic use.

Some psychedelics produce mild rhinorrhea during the come-up phase as part of a general parasympathetic activation that includes salivation, lacrimation, and increased GI motility. Dissociatives, particularly ketamine, can produce nasal discharge through both direct irritation (when insufflated) and autonomic effects.

Management is straightforward: tissues, hydration, and time. For opioid withdrawal rhinorrhea, clonidine or loperamide may provide symptomatic relief as part of a broader withdrawal management protocol. For insufflation-related rhinorrhea, saline nasal rinses after substance use help clear irritants and soothe the mucosa. Persistent or bloody nasal discharge warrants medical evaluation, particularly in chronic cocaine users.

How 4-AcO-DMT Produces This Effect

Upon entering the body, O-acetylpsilocin, or 4-AcO-DMT, is deacetylated to psilocin by deacetylases/acetyltransferases during first-pass metabolism and during subsequent passes through the liver (evident as psilacetin is also active via parenteral routes of ingestion).

The psychedelic effects of 4-AcO-DMT are believed to come from its activity as a partial agonist for the 5-HT2A receptor. However, the role of these interactions and how they result in the psychedelic experience is the subject of ongoing scientific investigation.

Claims of subjective differences in effects between the acetylated and non-acetylated forms of psilocin vary: some users report that O-acetylpsilocin lasts slightly longer, whilst others report that it lasts for a considerably shorter time. Many users report less body load and nausea compared with psilocin. Some users find that the visual effects produced by O-acetylpsilocin more closely resemble those produced by DMT than those produced by psilocin or psilocybin. These differences could be possible if psilacetin is psychoactive in itself and not merely as a prodrug. Despite this, there have been no controlled clinical studies to distinguish among the phenomenological effects of psilacetin, psilocin, and psilocybin.

Users frequently describe 4-AcO-DMT as being extremely similar to psilocybin mushrooms. It is generally described as euphoric, gentle, warm, and colorful. Visuals are reported by some users to be brighter and more neon in a manner reminiscent of DMT. It is also reported to be less nauseating than psilocybin mushrooms, which may be due to the fact that it does not require digesting mushroom matter.

Combination effects:

Cannabis - Cannabis is reported to strongly intensify the visual, sensory, and cognitive effects of 4-AcO-DMT. This combination should be used with extreme caution, as anecdotal reports suggest it increases the risk of experiencing a bad trip, characterized by anxiety, confusion, and psychosis.
Dissociatives - 4-AcO-DMT enhances the geometry, euphoria, dissociation and hallucinatory effects of all dissociatives, especially dissociative-induced holes, spaces, and voids. It may also significantly increase internal hallucinations, confusion, nausea, delusions and the chance of a psychotic reaction.
MDMA - 4-AcO-DMT strongly amplifies the visual, physical and cognitive effects of MDMA. The synergy between these substances is unpredictable, and it is best to start with lower doses than one would take for both substances individually. The toxicity risk of this combination is unknown, although there is some evidence that suggests this may increase the the neurotoxic effects of MDMA.
Alcohol - This combination is not typically advised due to alcohol’s potential to produce dehydration, nausea, and physical fatigue, which can negatively affect the experience (for moderate to high doses). This combination is, however, considered to be reasonably safe in low doses and, when used responsibly, can often "take the edge off" the experience by dulling 4-AcO-DMT's psychedelic effects in a manner somewhat similar to benzodiazepines.
Benzodiazepines - Depending on the dose, benzodiazepines can moderately to completely decrease the intensity of the cognitive, physical, and visual effects of a 4-AcO-DMT experience. They can be effective at mitigating bad trips by reducing excessive anxiety and hallucinations. Caution is advised when obtaining them for this purpose due to their high abuse potential.

Community Observations on Pharmacological Variability

A notable observation from experienced users who have used both 4-AcO-DMT and related tryptamines extensively is that set and setting produce a much larger variation in experience than the chemical differences between closely related tryptamines (such as 4-AcO-DMT vs. 4-HO-MET). Users with over 100 experiences with each compound have reported that the variability between trips on the same substance exceeds the average difference between the two substances, suggesting that individual neurochemical state and environmental context are dominant factors in the psychedelic experience.

Community members report that 4-AcO-DMT appears to have slightly more "body load" and a deeper, more emotionally introspective character compared to 4-HO-MET, which is described as lighter and more visually oriented. However, this distinction is not universal, and many users report trips on 4-AcO-DMT that are primarily visual and lighthearted, as well as trips on 4-HO-MET that are deeply emotional.

Some community members have noted that 4-AcO-DMT may produce slightly more nausea during the come-up phase compared to psilocybin mushrooms, while others report the opposite — less gastrointestinal discomfort with the synthetic compound than with mushroom material.

4-AcO-DMT can be administered via insufflated, oral. The route of administration can influence both the onset and intensity of runny nose.

Runny nose from 4-AcO-DMT

Runny nose + 4-AcO-DMT

Runny nose + 4-AcO-DMT

About Runny nose

Intensity Levels

Threshold

Light

Moderate

Strong

How 4-AcO-DMT Produces This Effect

Community Observations on Pharmacological Variability

Dosage Context

insufflated

oral

Other Substances That Cause Runny nose (8)

Psychedelic

Stimulant, Entactogen

Stimulants

Stimulants, Opioids

See Also

Frequently Asked Questions

Runny nose from 4-AcO-DMT

Runny nose + 4-AcO-DMT

Runny nose + 4-AcO-DMT

About Runny nose

Intensity Levels

Threshold

Light

Moderate

Strong

How 4-AcO-DMT Produces This Effect

Community Observations on Pharmacological Variability

Dosage Context

insufflated

oral

Other Effects from 4-AcO-DMT (103)

Other Substances That Cause Runny nose (8)

Psychedelic

Stimulant, Entactogen

Stimulants

Stimulants, Opioids

See Also

Frequently Asked Questions